OncoSynergy, Fighting Brain Cancer as the Family Business

OncoSynergy is a privately-held biotech company with a monoclonal antibody drug platform that is being developed for glioblastoma, the most aggressive form of brain cancer.

There is a great interview in Science Exchange this month with OncoSynergy's founder and CEO Shawn Carbonell, MD, PhD, and his wife, Anne-Marie Carbonell, MD, Vice President of Clinical Development.

In the interview, Shawn and Anne-Marie discuss their work on a drug that could be a game changer for patients with glioblastoma. They also talk about their involvement in the Race for Hope DC - the world's largest brain tumor community event, co-hosted by Accelerate Brain Cancer Cure and the National Brain Tumor Society.  OncoSynergy is the Social Media Sponsor of the 2014 Race for Hope DC.

Click HERE for the full article in Science Exchange.

Share |
December 4, 2014 02:02 PM
Concert proceeds benefit Accelerate Brain Cancer Cure.
November 24, 2014 04:43 PM
ABC2-funded research in the news and a blog post by Al Musella, of the Musella Foundation, about Novocure's promising Optune trial results.
November 18, 2014 12:33 PM
Accelerate Brain Cancer Cure funded Duke University's early work on the vaccine.

Join us in our fight for a cure!